SCIENTIFIC EVIDENCE

Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway

Evidence-based complementary and alternative medicine : eCAM

Yao H, Wei S, Xiang Y, Wu Z, Liu W, Wang B, Li X, Xu H, Zhao J, Gao Y.

Publication Overview

Key findings, Countstar context, and access to the original paper.

2019

Cell Counting & Viability

Key Finding

This study examines treatment responses in pulmonary fibrosis.

Countstar Connection

The researchers counted cells with the Countstar IC1000.

Stay Connected to

Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.

Meet us online